Lung Cancer: Targets and Therapy

SJR Rank #4,679H-index: 32SJR: 1.028Best quartile: Q2Open AccessAPC: US$2,320Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Dove Medical Press Ltd

Country

New Zealand

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • OncologyQ2

Areas: Medicine

Most published research topics

Lung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsCancer therapeutics and mechanismsHER2/EGFR in Cancer ResearchCancer-related Molecular PathwaysNeuroendocrine Tumor Research Advances

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs010203040

Documents per Year

2022202505101520

Detailed Information

ISSN

1179-2728

SJR Best Quartile

Q2

Region

Pacific Region

Citations per Document (2 years)

2.94

References per Document

50.61

Coverage

2010-2026

Scope

Lung Cancer: Targets and Therapy is an international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the best use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient. Specific topics covered in the journal include: Epidemiology, detection and screening; Cellular research and biomarkers; Identification of biotargets and agents with novel mechanisms of action; Optimal clinical use of existing anticancer agents, including combination therapies. The journal welcomes submitted papers covering original research, basic science, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, case reports and extended reports.

Metrics from SCImago Journal Rank 2025. View on SCImago